Tag: Kapvay

Originally developed as a medication for high blood pressure, clonidine has expanded its therapeutic uses to treat various conditions, including ADHD and opioid withdrawal. As a centrally acting alpha-agonist, it works by affecting nerve impulses in the brain to decrease heart rate and relax blood vessels.

First approved by the FDA decades ago for treating high blood pressure, clonidine is a versatile medication with a wide range of therapeutic applications. This centrally-acting alpha-agonist is now prescribed for managing attention deficit hyperactivity disorder (ADHD) and assisting with opioid withdrawal symptoms.

Kapvay (clonidine extended-release) was FDA-approved in 2009 for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, and can be used alone or with other stimulants. The medication works differently than traditional stimulants and offers a targeted approach to managing core ADHD symptoms.